Pricing Log in Create free account

Bone Biologics Corp. (BBLG) vs Lyra Therapeutics, Inc. (LYRA)

Bone Biologics Corp. and Lyra Therapeutics, Inc. are both Biotechnology companies. Bone Biologics Corp. is the larger, with a market value of $1.1M against $870.0K — 1.2× the size. Bone Biologics Corp. has the higher net margin (0.00% vs −7,266.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Bone Biologics Corp. leads on 9 and Lyra Therapeutics, Inc. on 1.

Valuation

Metric BBLG LYRA Biotechnology median
P/E n/m n/m 8.50
P/S n/m 0.74 9.71
P/B 0.18 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.51 0.64
EV/Sales n/m (39.19) 9.21
Earnings yield (342.50%) (10,078.95%) (33.15%)
Free cash flow yield (365.78%) (9,793.95%) (25.50%)

Profitability

Metric BBLG LYRA Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% (7,794.47%) 0.00%
Net margin 0.00% (7,266.08%) 0.00%
Free cash flow margin 0.00% (7,261.06%) 0.00%
Return on equity (54.96%) (6,594.98%) (56.36%)
Return on assets (50.55%) (56.45%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BBLG LYRA Biotechnology median
Revenue growth (TTM) — (74.05%) 6.02%
EPS growth (last fiscal year) 90.85% 73.96% 30.26%
Revenue growth, 5-year CAGR — (20.38%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BBLG LYRA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.67 1.71 4.72
Net debt to EBITDA 1.65 0.52 0.96

Dividend

Metric BBLG LYRA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BBLG LYRA Biotechnology median
Market cap 1.07m 870.00k 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack